Skip to main content
. 2016 Aug 27;31(2):e22044. doi: 10.1002/jcla.22044

Table 2.

Antibiotic susceptibilities and β‐lactamase detection of bla NDM‐1‐positive Enterobacter aerogenes (mg/l)

Isolate CZa GEN AM CTX CIP FEP FOX CRO TZP PIP IPM MEC AMK LVX CAZ ATM PB
0711 >8b >16 >32 >16 ≤1 >16 >16 >32 >64/4 >64 2 4 >32 ≤2 >16 >8 <2
0807 >8 >8 >16 >16 ≤1 >16 >16 >32 >64/4 >64 >8 2 >32 ≤2 >16 >8 <2
1311 >8 >16 >32 >32 ≤1 >32 >16 >32 >64/4 >64 4 8 >32 ≤2 >16 >8 <2
a

CZ, cefazolin; GEN, gentamicin; AM, Ampicillin; CTX, cefotaxime; CIP, ciprofloxacin; FEP, cefepime; FOX, cefoxitin; CRO, ceftriaxone; TZP, piperacillin/tazobactam(E‐test); PIP, piperacillin; IPM, imipenem(E‐test); MEC, meropenem(Etest); AMK, amikacin; LVX, levofloxacin; CAZ, ceftazidime; ATM, aztreonam; PB, polymyxin B(E‐test).

b

MICs were determined by the BD PhoenixTM‐100 automated bacterial identification susceptibility analyzers system or the E‐test. Where a “>“ sign is present in an entry with two values, the sign applies to both values in the entry. The second MIC refers to the second drug in the compound.